Feldberg buy marijuana

__________________________

📍 Verified store!

📍 Guarantees! Quality! Reviews!

__________________________

▼▼ ▼▼ ▼▼ ▼▼ ▼▼ ▼▼ ▼▼

▲▲ ▲▲ ▲▲ ▲▲ ▲▲ ▲▲ ▲▲

Feldberg buy marijuana

At the polls today, voters will not simply be voting Obama versus Romney. Referenda on ballots across the country allow voters to weigh in on the decisions of state and local governments, representing perhaps the purest form of direct democracy that exists in modern American politics. Several propositions appear today on the Massachusetts election ballot. From legalizing medical marijuana to physician? President of Tufts Republicans Bennett Gillogly , a junior, said. Question 1 comes with a bit of a caveat, as the state legislature already passed a so? Because the 'Right to Repair' law, which requires automakers to release diagnostic repair information, is already on the books, voters who support the law have the option of voting 'yes' or skipping the question. Voters' choices on questions 2 and 3, however, will have a more immediate impact on Massachusetts law. Question 2 asks voters whether physicians should be able to prescribe fatal medicine if requested by terminally ill patients with six months or less to live. To determine life expectancy, and whether the patient is mentally capable of making such a decision, two doctors must be involved. Both individual doctors and hospitals, however, can exempt themselves from the program. Feldberg's course included an examination of physician? Modeled after versions already enacted in Oregon and Washington, the Massachusetts Death with Dignity Act would establish a process for patient suicide that doctors could regulate. In Oregon, for example, 40 to 50 people each year have used this process to end their lives since the ballot initiative passed in , according to Feldberg. Without the option of euthanasia, terminally ill patients can choose to refuse treatment or their families may take them off life support, neither of which guarantee less pain and suffering, Feldberg said. Students discussed this issue, as well as Question 3, in an Oct. Although most attendees were in favor of this form of physician? Question 3 proposes the elimination of state criminal and civil penalties for the use of medical marijuana by patients with chronic or debilitating medical conditions. Unlike California's medical marijuana ballot initiative - often criticized for its lenient application - this ballot issue calls for relatively tighter regulation, according to Director of Government Relations for advocacy group Marijuana Policy Project Steve Fox LA ' Four years ago, the Massachusetts electorate voted to decriminalize non? During the talk hosted by IPC , students discussed the potential for the Massachusetts ballot to feature a question about legalizing all uses of marijuana in Some students who support Question 3 did, though, express concern about the power of the federal government in seizing the substance as well as the ambiguity of some of the proposition's language. Somerville residents will notice an additional ballot issue in Question 4, the Community Preservation Act, which has already been enacted in 42 percent of the state's municipalities. If passed, the act would facilitate a 1. Accumulated funds can only go toward the preservation of open spaces, historic resources and community housing. Somerville Mayor Joseph Curtatone, who proposed that the act be included on the ballot, spoke about the ways in which it could benefit the city at a Tufts Democrats meeting on Oct. For some, Question 4 directly affects the experience of Tufts students as members of the Somerville community. While some initiatives may seem minor, the various ballot questions offer residents the opportunity to decide significant community issues. Skip to Content , Navigation , or Footer. More from The Tufts Daily. Full-time lecturers, SMFA professors of the practice, engineering graduate workers hold protest amid ongoing union negotiations By Gus Gladstein October Tufts Health Service is now providing medication abortions. A year since Oct. Tweets by TuftsDaily. The Print Edition.

Lack of conclusive evidence on marijuana’s health effects poses public health risk

Feldberg buy marijuana

Federal government websites often end in. Before sharing sensitive information, make sure you're on a federal government site. The site is secure. NCBI Bookshelf. Marie C. McCormick, M. McCormick is a pediatrician with a second doctorate in health services research, with all of her postgraduate training done at Johns Hopkins. In she joined the faculty of the Department of Pediatrics at Harvard Medical School, and in she became a professor and the chair of the Department of Maternal and Child Health at the Harvard School of Public Health and a professor of pediatrics. Her research has focused on the effectiveness of perinatal and neonatal health services on the health of women and children with a particular concern in the outcomes of very premature infants. She has been a senior investigator on the evaluations of two national demonstration programs the Robert Wood Johnson Foundation National Perinatal Regionalization Program and, currently, the federal Healthy Start Program. In addition, she has provided significant scientific input, in a variety of roles, to the design and conduct of Infant Health and Development Project, the largest multisite, randomized trial of early childhood educational intervention, in particular, serving as the principal investigator of the follow-up done at 18 years of age. She is a member of the National Academy of Medicine, among other organizations. Her work on several committees, most notably the Immunization Safety Review Committee, has earned her the David Rall Medal for exceptional service. Donald I. Abrams, M. In he received funding from the National Institute on Drug Abuse to conduct a clinical trial of the short-term safety of cannabinoids in HIV infection. Subsequently he was granted funds by the University of California Center for Medicinal Cannabis Research to conduct studies of the effectiveness of cannabis in a number of clinical conditions. He completed a placebo-controlled study of smoked cannabis in patients with painful HIV-related peripheral neuropathy as well as a study evaluating vaporization as a smokeless delivery system for medicinal cannabis. His last National Institute on Drug Abuse—funded trial investigated the safety and pharmacokinetic interaction between vaporized cannabis and sustained-release opioid analgesics in patients with chronic pain. He is currently conducting a translational National Heart, Lung, and Blood Institute—funded trial investigating vaporized cannabis in patients with sickle cell disease. He received an A. After completing an internal medicine residency at the Kaiser Foundation Hospital in San Francisco, he became a fellow in hematology-oncology at UCSF, before joining the faculty. In , he completed a distance learning fellowship in integrative medicine from the University of Arizona and has since been providing integrative oncology consultations at the UCSF Osher Center for Integrative Medicine. She is also the co-PI of a William T. In , she was elected as a member of the National Academy of Medicine. The recipient of several awards, Dr. William Checkley, M. His areas of clinical expertise include epidemiology, pulmonary disease, and critical care medicine. Checkley also serves as the medical director for Johns Hopkins International. Checkley earned his M. He completed his internal medicine residency training at Emory University and his fellowship training in pulmonary and critical care medicine at Johns Hopkins School of Medicine. His research interests include international lung health, epidemiology, mechanical ventilation, and acute lung injury. He is certified in pulmonary disease and internal medicine by the American Board of Internal Medicine. Lorraine Collins, Ph. Collins's research interests include cognitive and behavioral approaches to the conceptualization, prevention, and treatment of addictive behaviors, particularly among emerging and young adults. Examples of her projects funded by the National Institutes of Health include a study to examine the combined use of alcohol and marijuana and a study of the use of technology in interventions to reduce marijuana use. Ziva D. Cooper, Ph. Cooper's primary research focus is translational studies investigating the effects of abused drugs and how these effects differ between males and females. For nearly a decade, she has been building on her training in preclinical models of drug dependence and developing an expertise in human laboratory studies on cannabis, cannabinoids, opioids, and cocaine while maintaining research projects in animal models of substance use. Her current research investigates the direct neurobiological effects of emerging drugs of abuse, including synthetic cannabinoids i. Adre J. In addition, Dr. Du Plessis is a leading international expert in the normal and abnormal development of the brain as well as the mechanisms of injury to the immature brain. His career-long research focus has been on the nervous system of the fetus and newborn, the hazards and mechanisms of injury, and the potential prevention of insult to the brain. Under his leadership, the Fetal Medicine Institute provides individualized and specialized care to patients during and after the baby's birth. Du Plessis received his M. In addition, he trained in child neurology at the St. Louis and Boston Children's Hospitals. Sarah Feldstein Ewing, Ph. Feldstein Ewing is a licensed clinical child psychologist with more than a decade of experience using a variety of evidence-based approaches to prevent and intervene with adolescent health risk behavior, including alcohol use, cannabis use, and human immunodeficiency virus HIV and acquired immune deficiency syndrome AIDS risk behavior. At this time, her lab has enrolled more than 1, youth within large-scale clinical trials to evaluate the developmental fit and treatment outcomes for motivational interviewing, behavioral skills training, cognitive behavioral approaches, mindfulness, and contingency management. She has published widely regarding the developmental fit, neurocognitive mechanisms, gender differences, and cross-cultural adaptation of these prevention and intervention approaches for this developmental stage. She has also developed a highly innovative National Institutes of Health—funded line of translational research, evaluating the connection between basic biological mechanisms e. She has conducted this work with alcohol-abusing adolescents, cannabis-abusing adolescents, adolescents engaged in risky sex, and youths with a high body mass index. Ultimately, the goal of her laboratory is to employ translational studies to 1 determine the driving factors underlying successful treatment outcomes, 2 develop more efficacious interventions, and 3 evaluate the efficacy of interventions in order to improve health outcomes and reduce the current disparities for high-risk adolescents of all backgrounds. Sean Hennessy, Pharm. His primary field of interest is pharmacoepidemiology, which is the study of the health effects of medications in populations. Kent Hutchison, Ph. He completed his Ph. After leaving Brown University, Dr. Hutchison accepted a faculty position at the University of Colorado Boulder. He was promoted to associate professor in and full professor in Hutchison moved to the Mind Research Network MRN in Albuquerque, New Mexico, to pursue a program of research combining neuroimaging, clinical outcomes, and genetics in , where he served as the chief science officer for 2 years. In he returned to the University of Colorado to help set up the Intermountain Neuroimaging Consortium, which involves the operation of two identical magnetic resonance scanners, one in Albuquerque at MRN and one in Boulder at the University of Colorado. He continues to serve as a liaison between the two organizations. Hutchison has a long track record of funding from the National Institutes of Health and publications. His research combines neuroimaging, epigenetic, pharmacological, and clinical perspectives. Recently he has focused on how inflammatory processes that result from alcohol abuse may damage important executive control circuits in the brain, ultimately contributing to loss of control over alcohol use. In large part because of the change in Colorado law legalizing cannabis, he has also become very interested in cannabinoids and has launched several studies to gather data about the effects of cannabis with different ratios of tetrahydrocannabinol to cannabidiol on a variety of measures, including measures related to cognitive function and immune system inflammation. Norbert E. Kaminski, Ph. Research being conducted in his laboratory is in the general areas of immunopharmacology and immunotoxicology and encompasses a number of extramurally funded projects. A major emphasis of all of these projects is the elucidation of the molecular mechanisms for the impairment of signal transduction cascades and gene expression during lymphocyte activation by drugs and chemicals. One major research focus is to characterize the mechanism for immune modulation by cannabinoid compounds. This effort has led to the first characterization of cannabinoid receptors within the immune system. Current goals include elucidation of signal transduction events initiated through—as well as independently of—cannabinoid receptors, including the peroxisome proliferator activated receptor PPARy , leading to aberrant cytokine gene expression by T lymphocytes. A second major research focus is the characterization of the molecular mechanism responsible for altered B cell function produced by halogenated aromatic hydrocarbons, including dioxins and polychlorinated biphenols. This research, which resulted in the first characterization of the aryl hydrocarbon AH receptor and aryl hydrocarbon receptor nuclear translocator in B cells, has led to testing of the hypothesis that dioxin and dioxin-like compounds suppress antibody responses by impairing B cell differentiation in an AH receptor-dependent manner. A third area of his research concerns studies aimed at characterizing the role of cytokine expression patterns in airway remodeling induced by chemical and protein respiratory allergens as well as by respiratory pathogens. Sachin Patel, M. Patel's overall research goal is to understand the role of neuronal cannabinoid signaling in brain function relevant to psychiatric disorders. His lab has recently focused specifically on the role of the cannabinoid system in the regulation of stress response physiology and the subsequent development of anxiety and depressive phenotypes relevant to affective disorders. The lab is using animal models to examine the effects of adolescent stress exposure on the cannabinoid system and cannabinoid-mediated synaptic plasticity in the amygdala, a key brain region implicated in affective disorders and developmental disorders, including autism. His lab is also interested in the role of cannabinoid signaling in modulating behavioral and synaptic alterations induced by very early life stress. Given that stress, especially early life stress, is associated with significantly higher rates of psychiatric disorders, including depression and posttraumatic stress disorder, understanding the cellular and molecular adaptations induced by stress exposure could provide opportunities for the development of novel therapeutic interventions for stress-related psychiatric disorders in children and adults. Another major focus of Dr. Patel's research is understanding the fundamental mechanisms of cannabinoid-mediated synaptic plasticity in the amygdala and how these forms of plasticity change during development. Understanding how the cannabinoid system modulates synaptic efficacy within emotional centers of the brain could provide mechanistic insight into developmental alterations induced by cannabis use during adolescence, which has been shown to be a risk factor for the development of psychiatric disorders, including schizophrenia. His lab is interested in understanding the mechanisms by which cannabis exposure early in life leads to an increased risk for the development of psychiatric disorders during adulthood. Daniele Piomelli, Ph. Piomelli was trained in neuroscience and pharmacology. Research in his lab is focused on the function of lipid-derived messengers, with particular emphasis on the endogenous cannabinoids anandamide and 2-arachidonoylglycerol. Current research efforts converge on three areas: the formation and deactivation of anandamide and 2-arachidonoylglycerol; physiological roles of the endogenous cannabinoid system; and development of therapeutic agents that target anandamide and 2-arachidonoylglycerol metabolism. Protein purification and cloning approaches are employed to characterize the molecular mechanisms underlying these processes. Cellular pharmacology and medicinal chemistry, in collaboration with leading international labs, are used to identify pharmacological agents that interfere with various aspects of endogenous cannabinoid function, and their therapeutic potential is explored in vitro and in vivo. Stephen Sidney, M. Sidney's research interests include cardiovascular diseases, including stroke, physical activity and fitness, cognitive function, and obesity, with an emphasis on health disparities. He conducted a National Institute on Drug Abuse—funded study from to on health outcomes associated with marijuana use utilizing survey and health outcome data from Kaiser Permanente Northern California, a large integrated health care system. He is the principal investigator of the Oakland field center of National Heart, Lung, and Blood Institute—funded Cardiovascular Risk Development in Young Adults CARDIA study, an ongoing year longitudinal study of cardiovascular risk and disease development in individuals who were 18—30 years old at baseline, which includes marijuana use data collected throughout the study period. Sidney has authored or co-authored more than peer-reviewed scientific publications covering a diverse range of topics, primarily in the area of cardiovascular epidemiology and also including more than 20 articles regarding epidemiological aspects of cannabis use and health outcomes. He received a B. Robert B. Wallace, M. He has a variety of public health experiences. He has conducted many population health studies as well as clinical trials, focusing on the prevention and control of chronic illnesses and other disabling conditions of older persons. These have included neurological conditions, fracture, cancers, coronary disease, mental illnesses, and the health of older women. He has continuing experience with community interventions related to the prevention of falls and motor vehicle injuries in older persons. He was a member of the U. He is currently involved in several actively funded research projects by NIH, including several related to nutritional issues. John Wiley Williams, M. He received his bachelor and M. Williams completed residency training at the University of Iowa and a research fellowship at Duke University. He is a primary care internist who is trained in epidemiology, biostatistics, and literature synthesis. Williams's topical interests include depression, mental health services, dementia, and the implementation of best practices. Williams directs the Durham VA Evidence Synthesis Program and has led numerous systematic reviews, many focusing on mental health services. Williams is board certified in internal medicine and active in clinical practice and resident physician education at the Durham VA Medical Center. Jennifer A. Cohen, M. She received her undergraduate degree and her M. Brownsyne Tucker Edmonds , M. Norman F. She went on to receive her medical degree from Brown Medical School, and, concurrently, completed a master's in public health at the Harvard School of Public Health with a concentration in quantitative methods. Tucker Edmonds trained in obstetrics and gynecology at Duke University Medical Center, where she served as an administrative chief resident in her final year. She then entered the Robert Wood Johnson Foundation Clinical Scholars Program fellowship at the University of Pennsylvania, where she received health services research training and a master's in health policy research. Her work currently focuses on communication and decision making in the management of periviable deliveries—when end-of-life decisions are made at the very beginning of life. Kelsey Geiser, M. Prior to her work at the National Academies, Ms. She has a B. Hope R. Hare, M. She keeps the board information updated, administers the twice-yearly board meeting, and provides support for the board director and staff. She holds an M. Leigh Miles Jackson, Ph. Prior to joining the National Academies, she was a developmental psychopathology and neurogenomics research fellow at Vanderbilt University, where she investigated the role of chronic sleep disturbance and specific epigenetic modifications on the health outcomes of adolescents. She has a bachelor's degree in chemistry from Wake Forest University and a Ph. Rose Marie Martinez, Sc. Martinez was a senior health researcher at Mathematica Policy Research — , where she conducted research on the impact of health system change on the public health infrastructure, access to care for vulnerable populations, managed care, and the health care workforce. She is a former assistant director for health financing and policy with the U. He recently graduated from American University with a B. Prior to the working at the National Academies of Sciences, Engineering, and Medicine, he worked within several health-focused organizations, including the American Cancer Society and the Windber Research Institute. Prior to joining the National Academies, Ms. Pinchon served as a Community Health Corps volunteer for Med-Star PromptCare, assisting underserved members of the community gain access to medical care. During this time she collaborated on research in the college's Human Computer Interaction Lab studying how the structure of play influences creativity in children. Kathleen Stratton, Ph. She has staffed committees addressing vaccine safety and development, pandemic preparedness, environmental and occupational health, drug safety, Medicare payment programs, and tobacco control. She was given the IOM Cecil Research Award in for sustained contributions to vaccine safety and was made a staff scholar in She received a B. Tharakan has a B. Here he has contributed to projects on nurse credentialing research, health standards for long-duration and exploration spaceflight, public health approaches to reduce vision impairment and promote eye health, and treatment of cardiac arrest. Prior to his work at the National Academies, Mr. Woodbury served in the U. Army as a combat medic and licensed practical nurse, and he later co-founded and managed a public health—oriented developmental aid project in Nepal. Woodbury's academic background is in philosophy, classics, and the history and philosophy of mathematics and science at St. John's College, as well as premedical studies at Johns Hopkins University. Turn recording back on. Help Accessibility Careers. Search term. Copyright by the National Academy of Sciences. All rights reserved. In this Page. Other titles in this collection. Recent Activity. Clear Turn Off Turn On. Follow NCBI.

Feldberg buy marijuana